Epidemiology issues in problem of antibiotic resistance of clinical pathogens
https://doi.org/10.33667/2078-5631-2020-34-6-8
Abstract
The relevance of the work is due to the increase in the number of hospital infections associated with antibiotic-resistant gram-negative pathogens on a global scale. For medical institutions, both from a clinical and economic point of view, the catastrophic situation is that the multidrug-resistant pathogens increasing leads to limited possible treatment options. Analysis of published scientific articles shows that today the strict epidemiological surveillance and the study of the pathogen resistance profile in each medical facility is an effective tool for controlling the growth of multidrug-resistant microorganisms, thus reducing morbidity and mortality.
About the Authors
N. I. Gabrielyan
National Medical Research Centre for Transplantology and Artificial Organs n. a. academician V. I. Shumakov
Russian Federation
Moscow
Russian Federation
Moscow
S. O. Sharapchenko
National Medical Research Centre for Transplantology and Artificial Organs n. a. academician V. I. Shumakov
Russian Federation
Moscow
Russian Federation
Moscow
O. V. Kisil
Scientific Research Institute for the Research of New Antibiotics n. a. G. F. Gauze
Russian Federation
Moscow
Russian Federation
Moscow
V. G. Kormilitsina
National Medical Research Centre for Transplantology and Artificial Organs n. a. academician V. I. Shumakov
Russian Federation
Moscow
Russian Federation
Moscow
I. V. Drabkina
National Medical Research Centre for Transplantology and Artificial Organs n. a. academician V. I. Shumakov
Russian Federation
Moscow
Russian Federation
Moscow
T. B. Safonova
Russian Medical Academy for Continuing Professional Education
Russian Federation
Moscow
Russian Federation
Moscow
M. I. Petrukhina
Russian Medical Academy for Continuing Professional Education
Russian Federation
Moscow
Russian Federation
Moscow
R. Sh. Saitgareev
National Medical Research Centre for Transplantology and Artificial Organs n. a. academician V. I. Shumakov
Russian Federation
Moscow
Russian Federation
Moscow
V. M. Zakharevich
National Medical Research Centre for Transplantology and Artificial Organs n. a. academician V. I. Shumakov
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. 2018; 18 (3): 318–327. DOI: 10.1016/S14733099(17)30753–3.
2. Brink AJ. Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 2019; 32 (6): 609–616. DOI: 10.1097/QCO.0000000000000608.
3. Rudnov V. A., Kolotova G. B., Bagin V. A., et al. The role of antimicrobial therapy management in the resuscitation and intensive care service of a multidisciplinary hospital. Clinical microbiology and antimicrobial chemotherapy. 2018: 20 (2): 132–14 (In Russ.)
4. La Fauci V, Costa GB, Arena A, et al. Trend of MDR-microorganisms isolated from the biological samples of patients with HAI and from the surfaces around that patient. New Microbiol. 2018; 41 (1): 42–46.
5. Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis. 2019; 69: S 521S 528. DOI: 10.1093/cid/ciz824.
6. Ma YX, Wang CY, Li YY, et al. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections. Adv Sci (Weinh). 2019; 7 (1): 1901872. DOI: 10.1002/advs.201901872.
7. Kisil O. V., Efimenko T. A., Gabrielyan N. I., Efremenkova O. V. Development of antimicrobial therapy methods to overcome antibiotic resistance of Acinetobacter baumannii. Acta Naturae. 2020; 3 (46): 34–45. DOI: 10.32607/actanaturae.10955.
8. Katchanov J, Asar L, Klupp EM, et al. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations. PLoS One. 2018; 13 (4): e0195757. DOI: 10.1371/journal.pone.0195757.
9. Rafat C, Messika J, Barnaud G, et al. Hypervirulent Klebsiella pneumoniae, a 5-year study in a French ICU. J Med Microbiol. 2018; 67 (8): 1083–1089. DOI: 10.1099/jmm.0.000788.
10. Huang H, Chen B, Liu G, et al. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii. BMC Infect Dis. 2018; 18 (1): 11. DOI: 10.1186/s12879–017–2932–5.
11. Russo A, Giuliano S, Ceccarelli G, et al. Comparison of septic shock due to multidrug-resistant Acinetobacter baumannii or Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in intensive care unit patients. Antimicrob Agents Chemother. 2018; 62 (6): e02562–17. DOI: 10.1128/AAC.02562–17.
12. Lee JS, Lee SH, Kim KS, et al. Bacterial infection monitoring in the early period after liver transplantation. Ann Surg Treat Res. 2018; 94 (3): 154–158. DOI: 10.4174/astr.2018.94.3.154.
13. Beloborodov B. V., Gusarov V. G., Dehnich A. V. et al. Diagnostika i antimikrobnaya terapiya infekcij, vyzvannyh polirezistentnymi mikroorganizmami. Vestnik anesteziologii i reanimatologii. 2020; 16 (1): 52–83. (In Russ.). DOI: 10.21292/2078–5658–2020–16–1–52–83.
14. Geladari A, Karampatakis T, Antachopoulos C, et al. Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department. Transpl Infect Dis. 2017; 19 (3): e12686. DOI: 10.1111/tid.12686.
15. Burillo A, Muñoz P, Bouza E. Risk stratification for multidrug-resistant Gram-negative infections in ICU patients. Curr Opin Infect Dis. 2019; 32 (6): 626–637. DOI: 10.1097/QCO.0000000000000599.
16. Tseng WP, Chen YC, Chen SY, et al. Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection. Antimicrob Resist Infect Control. 2018; 7: 93. DOI: 10.1186/s13756–018–0388-z.
17. Zemko V. Ju., Okulich V. K., Dzjadz’ko A. M. Monitoring antibiotikorezistentnosti mikroorganizmov v otdelenii reanimacii i intensivnoj terapii mnogoprofil’nogo stacionara. Transplantologiya. 2018; 10 (4): 284–297. (In Russ.). DOI: 10.23873/2074–0506–201810–4284–297.
18. Geladari A, Karampatakis T, Antachopoulos C, et al. Epidemiological surveillance of multidrug-resistant gram-negative bacteria in a solid organ transplantation department. Transpl Infect Dis. 2017; 19 (3): e12686. DOI: 10.1111/tid.12686.
19. Burillo A, Muñoz P, Bouza E. Risk stratification for multidrug-resistant Gram-negative infections in ICU patients. Curr Opin Infect Dis. 2019; 32 (6): 626–637. DOI: 10.1097/QCO.0000000000000599.
Review
For citations:
Gabrielyan N.I., Sharapchenko S.O., Kisil O.V., Kormilitsina V.G., Drabkina I.V., Safonova T.B., Petrukhina M.I., Saitgareev R.Sh., Zakharevich V.M. Epidemiology issues in problem of antibiotic resistance of clinical pathogens. Medical alphabet. 2020;(34):6-8. (In Russ.) https://doi.org/10.33667/2078-5631-2020-34-6-8
Views:
399
Email this article 